| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Access to care by Medicare beneficiaries in the U.S. with diabetes and multiple chronic conditions during the COVID-19 pandemic
|
Clements, John M.
|
|
|
36 |
12 |
p.
|
article
|
| 2 |
Contents/Barcode
|
|
|
|
36 |
12 |
p.
|
article
|
| 3 |
Distal symmetrical polyneuropathy is present in all individuals with diabetes and foot ulcers - and does not associate with healing time
|
Mizrak, Hatice Isik
|
|
|
36 |
12 |
p.
|
article
|
| 4 |
Extent of subclinical atherosclerosis on coronary computed tomography and impact of statins in patients with diabetes without known coronary artery disease: Results from CONFIRM registry
|
Shaikh, Kashif
|
|
|
36 |
12 |
p.
|
article
|
| 5 |
Metabolic effects of the dual SGLT 1/2 inhibitor sotagliflozin on blood pressure and body weight reduction in people with diabetes: An updated meta-analysis of randomized controlled trials
|
Wu, Jiangfan
|
|
|
36 |
12 |
p.
|
article
|
| 6 |
Neurohumoral response and stress hyperglycemia in myocardial infarction
|
Swieszkowski, Sandra Patricia
|
|
|
36 |
12 |
p.
|
article
|
| 7 |
Obesity and nonalcoholic fatty liver disease in type 1 diabetes mellitus patients
|
Muzurović, Emir
|
|
|
36 |
12 |
p.
|
article
|
| 8 |
Obesity, but not glycemic control, predicts liver steatosis in children with type 1 diabetes
|
Tas, Emir
|
|
|
36 |
12 |
p.
|
article
|
| 9 |
Peripheral sensory nerve function, type 2 diabetes and frailty among men with cardiovascular disease
|
Lutski, Miri
|
|
|
36 |
12 |
p.
|
article
|
| 10 |
Present and future directions in diabetic kidney disease
|
Limonte, Christine P.
|
|
|
36 |
12 |
p.
|
article
|
| 11 |
Regulation of glucose transporter-4 intervention with S. saman leaves extract in streptozotocin-induced diabetic rats
|
Vinodhini, Shanmugam
|
|
|
36 |
12 |
p.
|
article
|
| 12 |
Skin advanced glycation end products as a screening tool of neuropathy in type 2 diabetes mellitus
|
Papachristou, Stella
|
|
|
36 |
12 |
p.
|
article
|
| 13 |
Tirzepatide: A novel, first-in-class, dual GIP/GLP-1 receptor agonist
|
Tall Bull, Shasta
|
|
|
36 |
12 |
p.
|
article
|
Journal description